CADL 10-Q: SEC filing
Candel Therapeutics
Filed with the SEC on · accession 0001193125-26-458380
CADL filed a 10-Q (quarterly report) with the SEC on Nov 12, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -9.0% by the first close after the filing.
Summary of the filing
Candel Therapeutics filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing routine financial results and operational updates including a new Trinity Capital term loan agreement and equity plan amendments.
Key details
How CADL stock reacted
Close before
$9.22
Nov 11, 2026
First close after
-9.00%
$8.39
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for CADL, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for CADL?
Click hereFrequently asked questions
What did CADL file with the SEC on Nov 12, 2026?
CADL filed a 10-Q (SEC filing). Candel Therapeutics filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing routine financial results and operational updates including a new Trinity Capital term loan agreement and equity plan amendments.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did CADL stock react to this filing?
CADL closed at $9.22 before the filing and $8.39 on Nov 12, 2026 (-9.00%).
Other CADL SEC filings
- 8-K · Shelf registrationNov 12, 2026
- 8-K · SEC filingNov 12, 2026
- 424B5 · Shelf registrationNov 12, 2026
- 8-K · Board changeSep 10, 2026
- 8-K · SEC filingSep 9, 2026
- 8-K · SEC filingAug 13, 2026
- 10-Q · SEC filingAug 13, 2026
- 144 · Insider sale plannedJun 29, 2026
- 144 · Insider sale plannedJun 29, 2026
- 8-K · Board changeJun 24, 2026
Get alerts when CADL files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days